Borderline Low Free Testosterone: Do You Meet Criteria for Hypogonadism?
You do not meet diagnostic criteria for hypogonadism based on a single borderline-low free testosterone measurement alone. Diagnosis requires both confirmed biochemical deficiency through repeated morning total testosterone measurements AND specific symptoms—primarily diminished libido or erectile dysfunction—neither of which you mention. 1
Why Your Single Test Is Insufficient
Two separate fasting morning (8–10 AM) total testosterone measurements below 300 ng/dL are mandatory to confirm biochemical hypogonadism, not a single free testosterone value. 1, 2, 3 Laboratory reference ranges for testosterone vary dramatically across facilities—lower limits range from 130 to 450 ng/dL (a 350% difference)—making single borderline results unreliable for diagnosis. 4, 5
Free testosterone should be measured by equilibrium dialysis (the gold standard) or calculated using validated formulas when total testosterone is near the lower limit of normal or in men with conditions that alter sex hormone-binding globulin (SHBG), such as obesity or diabetes. 2, 6, 3 Direct immunoassays for free testosterone are notoriously inaccurate and should not guide treatment decisions. 1, 2
Required Diagnostic Steps
1. Confirm Low Testosterone With Repeat Testing
- Obtain two separate fasting morning total testosterone measurements (8–10 AM) on different days using a highly accurate assay (liquid chromatography-tandem mass spectrometry certified by the CDC Hormone Standardization Program). 1, 6, 3
- Both values must be < 300 ng/dL to establish biochemical hypogonadism. 1, 3
- If total testosterone falls in the "gray zone" (231–346 ng/dL), measure free testosterone by equilibrium dialysis or calculate it using the Vermeulen formula (requires total testosterone, SHBG, and albumin). 1, 2, 3
2. Assess for Qualifying Symptoms
Testosterone therapy is justified ONLY for diminished libido and erectile dysfunction—the only symptoms with proven responsiveness to replacement. 1
Symptoms that do NOT justify treatment even with confirmed low testosterone:
- Fatigue or low energy (effect size 0.17, clinically insignificant) 1
- Depressed mood (effect size -0.19, "less-than-small") 1
- Poor concentration or "brain fog" 1
- Reduced physical strength or muscle mass 1
3. Differentiate Primary vs. Secondary Hypogonadism
- Measure LH and FSH after confirming low testosterone. 1, 3
- Low/normal LH-FSH = secondary (hypothalamic-pituitary) hypogonadism → potentially reversible causes or fertility-preserving options. 1
- Elevated LH-FSH = primary (testicular) hypogonadism → testosterone replacement only option. 1
What to Expect If Hypogonadism Is Confirmed
Realistic treatment outcomes (assuming you have qualifying sexual symptoms):
- Small improvement in sexual function and libido (standardized mean difference 0.35). 1
- No meaningful benefit for energy, mood, physical function, or cognition—effect sizes are negligible even in confirmed hypogonadism. 1
- Modest quality-of-life gains confined to sexual domains only. 1
Critical Pitfalls to Avoid
- Never diagnose hypogonadism on symptoms alone without two confirmed morning total testosterone values < 300 ng/dL. 1, 3
- Never rely on a single testosterone measurement—diurnal variation and assay differences create false positives. 1, 4, 5
- Never use direct immunoassays for free testosterone in men with abnormal SHBG; demand equilibrium dialysis or calculated values. 1, 2, 6
- Never initiate therapy for nonspecific symptoms (fatigue, mood changes) expecting improvement—the evidence shows no benefit. 1
Next Steps
- Repeat morning total testosterone (8–10 AM) on at least one additional occasion. 1, 3
- If both values < 300 ng/dL, measure free testosterone by equilibrium dialysis or calculate using the Vermeulen formula. 1, 2, 3
- Obtain LH and FSH to classify primary vs. secondary hypogonadism. 1, 3
- Assess for specific symptoms (diminished libido, erectile dysfunction). 1
- Initiate treatment only when both biochemical hypogonadism and qualifying symptoms are present. 1, 3
Approximately 20–30% of men receiving testosterone therapy do not actually meet diagnostic criteria—a consequence of variable reference ranges and inadequate confirmatory testing. 1, 4, 5 Do not become part of this statistic by pursuing treatment based on a single borderline result without proper evaluation.